SORT OUT III Data Presented at American College of Cardiology reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic’s Endeavor(R) Stent highlighting significant and sustained clinical differences.

The findings report that the CYPHER(R) Stent was associated with significantly lower rates of death, myocardial infarction, and repeat procedures than the Endeavor(R) Stent out to 18 months. This information was also published in the Lancet Journal.

To read the full story, click here.